New drug tested against eight tough cancers

NCT ID NCT06084481

Ongoing Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing an experimental drug called ABBV-400 in adults with advanced solid tumors that have spread or cannot be removed by surgery. It includes eight specific cancer types, such as liver, pancreatic, and certain breast cancers. The main goals are to check the drug's safety, see what side effects occur, and measure if it helps shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Aichi Cancer Center Hospital /ID# 256679

Nagoya, Aichi-ken, 464-8681, Japan
Austin Health /ID# 256635

Heidelberg, Victoria, 3084, Australia
China Medical University Hospital /ID# 256712

Taichung, 40447, Taiwan
Chris O'Brien Lifehouse /ID# 262765

Camperdown, New South Wales, 2050, Australia
Chungbuk National University Hospital /ID# 256698

Cheongju-si, North Chungcheong, 28644, South Korea
City of Hope National Medical Center /ID# 258645

Duarte, California, 91010, United States
Clinica Universidad de Navarra - Madrid /ID# 264042

Madrid, 28027, Spain
Clinica Universidad de Navarra - Pamplona /ID# 256703

Pamplona, Navarre, 31008, Spain
Duke Cancer Center /ID# 255129

Durham, North Carolina, 27710, United States
E-DA Cancer Hospital /ID# 258880

Kaohsiung City, Kaohsiung, 82445, Taiwan
Florida Cancer Specialists /ID# 261569

Sarasota, Florida, 34232, United States
Gyeongsang National University Hospital /ID# 260408

Jinju, Gyeongsangnam-do, 52727, South Korea
Hadassah Medical Center-Hebrew University /ID# 256655

Jerusalem, 91120, Israel
Hospital General Universitario Gregorio Maranon /ID# 262816

Madrid, 28007, Spain
Hospital HM Nou Delfos /ID# 263953

Barcelona, 08023, Spain
Hospital Quirón Málaga /ID# 263994

Málaga, Malaga, 29004, Spain
Hospital Universitario Fundacion Jimenez Diaz /ID# 256702

Madrid, 28040, Spain
Hospital Universitario HM Sanchinarro /ID# 256701

Madrid, 28050, Spain
Hospital Universitario Miguel Servet /ID# 256704

Zaragoza, 50009, Spain
Inje University Haeundae Paik Hospital /ID# 260118

Busan, Busan Gwang Yeogsi, 48108, South Korea
Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 262771

Fairfax, Virginia, 22031, United States
Institut Català d'Oncologia (ICO) - Badalona /ID# 263954

Badalona, Barcelona, 08916, Spain
Korea University Guro Hospital /ID# 256700

Seoul, Seoul Teugbyeolsi, 08308, South Korea
Kyoto University Hospital /ID# 256680

Kyoto, Kyoto, 606-8507, Japan
Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693

Providence, Rhode Island, 02903-4923, United States
Linkou Chang Gung Memorial Hospital /ID# 259420

Taoyuan, 333, Taiwan
MD Anderson Cancer Center /ID# 255131

Houston, Texas, 77030, United States
MUSC Hollings Cancer Center /ID# 257935

Charleston, South Carolina, 29425, United States
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255132

New York, New York, 10065-6007, United States
NHO Nagoya Medical Center /ID# 261001

Nagoya, Aichi-ken, 460-0001, Japan
National Cancer Center Hospital /ID# 261136

Chuo-Ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East /ID# 258934

Kashiwa-shi, Chiba, 277-8577, Japan
National Taiwan University Hospital /ID# 256713

Taipei City, Taipei, 100, Taiwan
Northwestern University Feinberg School of Medicine /ID# 257378

Chicago, Illinois, 60611-2927, United States
Pan American Center for Oncology Trials /ID# 262903

Rio Piedras, 00935, Puerto Rico
Prisma Health /ID# 257697

Greenville, South Carolina, 29605, United States
Rabin Medical Center. /ID# 256650

Petah Tikva, 4941492, Israel
Rambam Health Care Campus /ID# 256649

Haifa, 3109601, Israel
START Midwest /ID# 256581

Grand Rapids, Michigan, 49546-7062, United States
Samsung Medical Center /ID# 258933

Seoul, Seoul Teugbyeolsi, 06351, South Korea
Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926

Denver, Colorado, 80218, United States
Seoul National University Hospital /ID# 255730

Seoul, Seoul Teugbyeolsi, 03080, South Korea
Shizuoka Cancer Center /ID# 257789

Sunto-gun, Shizuoka, 411-8777, Japan
South Texas Accelerated Research Therapeutics /ID# 260404

San Antonio, Texas, 78229, United States
Tel Aviv Sourasky Medical Center /ID# 258931

Tel Aviv, Tel Aviv, 6423906, Israel
Tennessee Oncology-Nashville Centennial /ID# 261568

Nashville, Tennessee, 37203-1632, United States
The Cancer Institute Hospital Of JFCR /ID# 257788

Koto-ku, Tokyo, 135-8550, Japan
The Chaim Sheba Medical Center /ID# 255731

Ramat Gan, Tel Aviv, 5265601, Israel
Ucsf /Id# 257705

San Francisco, California, 94143, United States
Univ Hosp Cleveland /ID# 257706

Cleveland, Ohio, 44106, United States
Univ Texas HSC San Antonio /ID# 257708

San Antonio, Texas, 78229-3901, United States
University of Chicago Medical Center /ID# 258197

Chicago, Illinois, 60637, United States
University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128

Aurora, Colorado, 80045-7158, United States
Washington University-School of Medicine /ID# 257379

St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT CANCERS ESOPHAGEAL SQUAMOUS CELL CARCINOMA HEAD AND NECK SQUAMOUS CELL CARCINOMA HEPATOCELLULAR CARCINOMA HORMONE RECEPTOR+/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE BREAST CANCER PANCREATIC DUCTAL ADENOCARCINOMA PLATINUM RESISTANT HIGH GRADE EPITHELIAL OVARIAN CANCER TRIPLE NEGATIVE BREAST CANCER